Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of Trastuzumab

PURPOSE: The Herceptin Adjuvant study is an international multicenter randomized trial that compared 1 or 2 years of trastuzumab given every 3 weeks with observation in women with human epidermal growth factor 2–positive (HER2+) breast cancer after chemotherapy. Identification of biomarkers predicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Scooter, Polydoropoulou, Varvara, Sun, Yuliang, Young, Brandon, Tsourti, Zoi, Karlis, Dimitris, Long, Bradley, Lin, Xiaoqian, Theel, Stephanie, Carlson, Jennifer, Győrffy, Balazs, Williams, Casey, Abramovitz, Mark, Dafni, Urania, Dowsett, Mitch, Leyland-Jones, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446467/
https://www.ncbi.nlm.nih.gov/pubmed/32913993
http://dx.doi.org/10.1200/PO.18.00016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446467/
https://www.ncbi.nlm.nih.gov/pubmed/32913993
http://dx.doi.org/10.1200/PO.18.00016

Ejemplares similares